You can now register for the 7th Clinical Trials on Alzheimer’s Disease (CtaD) to be held in Philadelphia, November 20-22, 2014.
Alzheimer’s disease is one of the most important health challenges facing aging populations worldwide. The development of the next generation of Alzheimer’s disease drugs is becoming essential to face up to this challenge. We learned in San Diego of new pathways identified with biomarkers, facilitating novel trial designs for studies of tau-based therapies and other disease-modifying drugs including immunotherapy.
We are looking forward to making CtaD 2014 scientifically and clinically challenging, be part of this exciting program submit today your abstract for a symposium, oral communication or poster presentation! Deadline is June 10th.
See you in Philadelphia!
Paul Aisen, MD University of California San Diego (UCSD)
Jacques Touchon, MD, PhD University Hospital of Montpellier, France
Bruno Vellas, MD, PhD University Hospital of Toulouse, France
Mike Weiner, MD University of California San Francisco (UCSF)